Coadministration of mRNA-1345 RSV vaccine with high-dose quadrivalent influenza vaccine in adults aged 65 and older: An observer-blinded, placebo-controlled, randomized, phase 3 trial.
mRNA-1345 RSV Vaccine + High-Dose Flu Vaccine in Older Adults: Coadministration Efficacy & Safety
Quick Take: Coadministration of mRNA-1345 RSV vaccine with a high-dose quadrivalent influenza vaccine in adults 65+ demonstrates non-inferior immunogenicity for both vaccines and an acceptable safety profile, suggesting a viable strategy for combined administration.
💡 Clinical Impact
* Mechanistic